Promote Sponsor
verified SJR 0,493 · Q3 • database Scopus / SJR & Web of Science indexed
Biomarkers in Medicine
United Kingdom · Taylor and Francis Ltd.
workspace_premium Q3 — Drug Discovery lock Subscription Unclaimed

Biomarkers in Medicine

Biomarkers in Medicine is a journal indexed in SJR in Drug Discovery and Biochemistry (medical) with an H index of 59. It has an SJR impact factor of 0,493 and it has a best quartile of Q3. It has an SJR impact factor of 0,493.

Biomarkers in Medicine focuses its scope in these topics and keywords: pharmacogenomic, clinical, function, era, therapy, factors, triage, making, genome, causal, ...

ISSN: 1752-0363
Editorial: Taylor and Francis Ltd.
Category: Drug Discovery
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
0,493 Q3
H-index 59
Tasa de Aceptación pie_chart
31%
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,493

H-index

59

Docs (year)

110

Docs 3y

366

Total refs

4763

Cites 3y

622

Citable 3y

355

Cites/Doc 2y

1.82

Ref/Doc

43.3

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biomarkers of multiorgan injury in neonatal encephalopathy

View more

Using biomarkers to detect oral cancer holds potential for saving lives when the cancer is most curable

View more

Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients

View more

Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results

View more

Company Profile: Caprion Proteomics, Inc.

View more

Companion diagnostics at the intersection of personalized medicine and healthcare delivery

View more

Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis

View more

Clinical characteristics and biomarkers analysis of asthma inflammatory phenotypes

View more

Classical and new assays for detecting drug resistance in tuberculosis

View more

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function

View more

Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?

View more

Book Review: Biomarkers in drug development: a handbook of practice, application and strategy

View more
SHOW MORE ARTICLES

Biomarkers of susceptibility following benzene exposure: influence of genetic polymorphisms on benzene metabolism and health effects

View more

A window into your heart: taking cardiac troponin to the next level

View more

Biomarkers for understanding Ebola virus disease

View more

Biomarkers for invasive aspergillosis: the challenges continue

View more

Biomarkers for breast cancer stem cells: the challenges ahead

View more

Biomarker tests for fetal lung maturity

View more

Biomarker discovery for childhood infections: paving the way for a diagnostic revolution in the developing world

View more

Beyond biomarkers: an opportunity to address the 'pharmacodynamic gap' in pediatric drug development

View more

Association between polymorphisms of glutathioneS-transferase genes (GSTM1,GSTP1andGSTT1) and breast cancer risk in a sample Iranian population

View more

Approaches to biomarkers in human colorectal cancer: looking back, to go forward

View more

Applications of 'decisionable' biomarkers in cardiovascular drug development

View more

Analytical aspects of molecular Alzheimer's disease biomarkers

View more

FAQS